Erdei; James Joseph

Patent Applications and Registrations

Patent applications and USPTO patent grants for Erdei; James Joseph.The latest application filed is for "amino-5-(5-membered)heteroarylimidazolone compounds and the use thereof for beta-secretase modulation".

Company Profile

0.5.12

Erdei; James Joseph - Flourtown PA
Erdei; James Joseph - Philadelphia PA
Erdei; James Joseph - Feasterville PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted imidazo[1,5-a]quinoxalines useful as inhibitors of phosphodiesterase 10 for the treatment of neurological and other disorders Grant 7,875,618 - Malamas , et al. January 25, 2	2011-01-25
Amino-5-(5-membered)heteroarylimidazolone Compounds And The Use Thereof For Beta-secretase Modulation App 20100168106 - Malamas; Michael Sotirios ; et al.	2010-07-01
Imidazo[5,1-c][1,2,4]benzotriazine Derivatives As Inhibitors Of Phosphodiesterases App 20100120763 - Stange; Hans ; et al.	2010-05-13
Triazine derivatives as inhibitors of phosphodiesterases App 20100120762 - Stange; Hans ; et al.	2010-05-13
Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for .beta.-secretase modulation Grant 7,705,030 - Malamas , et al. April 27, 2	2010-04-27
Amino-imidazolones For The Inhibition Of Beta-secretase App 20090253716 - Malamas; Michael Sotirios ; et al.	2009-10-08
Diphenylimidazopyrimidines as inhibitors of .beta.-secretase Grant 7,563,796 - Malamas , et al. July 21, 2	2009-07-21
Pyrido[3,2-E]Pyrazines, Process For Preparing The Same, And Their Use As Inhibitors Of Phosphodiesterase 10 App 20090143361 - Malamas; Michael S. ; et al.	2009-06-04
ARYL AND HETEROARYL FUSED IMIDAZO[1,5-a]PYRAZINES AS INHIBITORS OF PHOSPHODIESTERASE 10 App 20090143367 - Malamas; Michael S. ; et al.	2009-06-04
Amino-5-[4-(difluoromethoxy) Phenyl]-5-phenylimidazolone Compounds For The Inhibition Of Beta-secretase App 20090012139 - MALAMAS; Michael Sotirios ; et al.	2009-01-08
AMINO-5-(5-MEMBERED)HETERO-ARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR beta-SECRETASE MODULATION App 20080306091 - Malamas; Michael Sotirios ; et al.	2008-12-11
Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds for the inhibition of .beta.-secretase Grant 7,423,158 - Malamas , et al. September 9, 2	2008-09-09
Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for .beta.-secretase modulation Grant 7,417,047 - Malamas , et al. August 26, 2	2008-08-26
Amino-5-[4-(difluoromehtoxy)phenyl]-5-phenylimidazolone compounds for the inhibition of beta-secretase App 20070072925 - Malamas; Michael Sotirios ; et al.	2007-03-29
Cycloalkyl amino-hydantoin compounds and use thereof for beta-secretase modulation App 20070027199 - Malamas; Michael Sotirios ; et al.	2007-02-01
Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for beta-secretase modulation App 20070004786 - Malamas; Michael Sotirios ; et al.	2007-01-04
Amino-imidazolones for the inhibition of beta-secretase App 20060160828 - Malamas; Michael Sotirios ; et al.	2006-07-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.